Skip to content
devi
CERTS
Devices
Categories
Manufacturers
Importers
Certifiers
Authorities
Reps.
Representatives
Categories
/
Gastrointestinal devices
/
Orally administered gastrointestinal devices
Orally administered gastrointestinal devices
G04
1,883 devices
Subcategories
3
G0401
Orally administered devices for the therapy of gastro-intestinal disorders
759
devices
G0402
Orally administered devices for appetite control and reduction of intestinal absorption
1,010
devices
G0499
Orally administered gastrointestinal devices - other
114
devices
Devices
GascolDuo (20 tablets)
S.I.I.T. srl
·
,
Italy
Class IIa
CE/MDD
Assista Simeticona Baby
Fiterman Pharma SRL
·
,
Romania
Class IIb
CE/MDR
Flinndal IBS 30 caps
PK Benelux BV
·
,
Netherlands
Class IIa
CE/MDD
Activemed Reizdarmsyndrom
PK Benelux BV
·
,
Netherlands
Class IIa
CE/MDD
BALONIX MED chewable tablets
Fiterman Pharma SRL
·
,
Romania
Class IIa
CE/MDD
Ergeo (24 tablets)
S.I.I.T. srl
·
,
Italy
Class IIa
CE/MDD
Entogol (10 sachets)
S.I.I.T. srl
·
,
Italy
Class IIa
CE/MDD
ForlaxGo
Mayoly Pharma France
·
,
France
Class IIa
CE/MDD
Reflu Mag
Gruppo Farmaimpresa SRL
·
,
Italy
Class IIa
CE/MDD
Neobianacid
Aboca S.P.A. Società Agricola
·
,
Italy
Class III
CE/MDR
×2
Active
Valid to Mar 2028
Stomaxil Calm ES
Labomar S.p.A.
·
,
Italy
Class IIb
CE/MDD
Neobianacid
Aboca S.P.A. Società Agricola
·
,
Italy
Class III
CE/MDR
×2
Active
Valid to Mar 2028
Kruidvat Macrogol (10 sachets)
S.I.I.T. srl
·
,
Italy
Class IIa
CE/MDD
Neobianacid
Aboca S.P.A. Società Agricola
·
,
Italy
Class III
CE/MDR
×2
Active
Valid to Mar 2028
Kijimea® Colon Irritable Pro
Synformulas GmbH
·
,
Germany
Class IIb
CE/MDR
Neobianacid
Aboca S.P.A. Società Agricola
·
,
Italy
Class III
CE/MDR
×2
Active
Valid to Mar 2028
Neobianacid
Aboca S.P.A. Società Agricola
·
,
Italy
Class III
CE/MDR
×2
Active
Valid to Mar 2028
Macrogol Beta Lemon
Fairpharm Vertriebs GmbH
·
,
Germany
Class IIb
CE/MDR
DICOPEG FREE (14 sachets)
S.I.I.T. srl
·
,
Italy
Class IIa
CE/MDD
ibesan MAX
Natur Produkt Zdrovit Sp. z o.o.
·
,
Poland
Class IIb
CE/MDR
TNP/MDR/0048/5905/2026
Active
Valid to Feb 2029
Previous
Next